Skip to content

ProPhase Labs, Inc.

PRPH· OTCCore metricsCIK 868278

Pharmaceutical preparations552 peers

Close
Jul 2, 2026
Market cap
$1.12M
14.02M shares
Filings
924
$1.01M
Q2 2026−35.8% FY25 yoy
-$3.05M
Q2 2026N/M FY25 yoy
-$2.65M
Q2 2026N/M FY25 yoy
-$8.34M
FY 2025derivedN/M FY25 yoy
-$0.22
Q2 2026N/M FY25 yoy
$20.00K
Q2 2026−86.7% FY25 yoy
$1.12M
—
0.3×
—
—
—

Twelve months to Jun 30, 2026 · derived

Price

$0.0897.91%$3.75past year
Jul 2, 2026 · Official close
Figure
Range
IEX last saleClose of record

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$4.35MFY 2025
$122.65M0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$4,345,000reported
FY 20242024-12-31$6,770,000reported
FY 20232023-12-31$34,984,000 revisedreported
FY 20222022-12-31$122,647,000reported
FY 20212021-12-31$79,042,000reported
FY 20202020-12-31$14,514,000reported
FY 20192019-12-31$9,876,000reported
FY 20182018-12-31$13,126,000reported
FY 20172017-12-31$9,867,000reported
FY 20162016-12-31$4,206,000 revisedreported
FY 20152015-12-31$2,518,000 revisedreported
FY 20142014-12-31$22,070,000reported

Capital returns

Dividends and buybacks · FY2009 to FY2024
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2024—$0.00$0.00—41.88M sh+132.1%—
FY2023$0.00$588.00K$588.00K—18.05M sh+5.0%—
FY2022$9.35M$2.15M$11.51M$0.3017.18M sh+11.0%46.7%
FY2021$4.55M$917.00K$5.46M$0.3015.49M sh+2.2%—
FY2019$5.82M—$5.82M—11.58M sh+0.2%—

Segments

Revenue by Segments, FY2019 to FY2025FY2019Consumer Products · FY2019 · $9.88MFY2020Consumer Products · FY2020 · $13.24MDiagnostic Services · FY2020 · $1.28MFY2021Consumer products · FY2021 · $10.48MDiagnostic Services · FY2021 · $68.56MConsumer Products · FY2021 · $10.48MDiagnostic Services · FY2021 · $68.56MFY2022Consumer products · FY2022 · $14.32MDiagnostic Services · FY2022 · $108.33MFY2023Consumer products · FY2023 · $10.14MDiagnostic Services · FY2023 · $24.85MFY2024Consumer products · FY2024 · $6.77MFY2025Consumer products · FY2025 · $4.35M
LineFY2025ShareChange
Consumer products$4.35M100%−35.8%
Diagnostic Services$0.00——
Consumer Products———
Diagnostic Services———
Total$4.35M

From the 10-K filed Jun 1, 2026PRPH

Pharmaceutical preparations

ProPhase Labs, Inc. is the 189th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR